2010
DOI: 10.4103/0256-4947.65255
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine

Abstract: BACKGROUND AND OBJECTIVES:Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Little is known about cardiovascular risk factors in patients with PCOS. We investigated plasma markers of cardiovascular disease in Saudi women with PCOS, with an emphasis on asymmetric dimethylarginine (ADMA) and total homocysteine (tHcy).PATIENTS AND METHODS:Fifty Saudi women with PCOS diagnosed by the Rotterdam criteria (mean age [SD] 30.2 [3.0] years) a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
17
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 29 publications
4
17
0
1
Order By: Relevance
“…Its plasma concentration was significantly higher in women with PCOS than in healthy control groups (67). The possible mechanism of elevation of ADMA in hyperhomocysteinemia includes a reduced renal excretion (68) and a decreased activity of the hydrolase enzyme, which metabolizes ADMA (69).…”
Section: Pcos and Homocysteinementioning
confidence: 86%
“…Its plasma concentration was significantly higher in women with PCOS than in healthy control groups (67). The possible mechanism of elevation of ADMA in hyperhomocysteinemia includes a reduced renal excretion (68) and a decreased activity of the hydrolase enzyme, which metabolizes ADMA (69).…”
Section: Pcos and Homocysteinementioning
confidence: 86%
“…High leukocyte count, an increase in inflammatory markers such as C-reactive protein (CRP) and cytokines [3][4][5][6], and an association between these markers and atherosclerotic heart disease [7,8] have been shown in women with PCOS.…”
Section: Introductionmentioning
confidence: 98%
“…Our findings are also consistent with those of Ahmed M. Mohamadin et al, Mine Yavuz Taslipnar et al and on the other hand, Nacul et al, Kuscu et al, Erdagon et al did not observe significant differences in terms of NO in their studies between PCOS patients and healthy controls. [17][18][19][20][21] However Karabulut AB et al showed increased NO levels in PCOS group when compared to healthy control. 22 In present study NO negatively correlated with insulin resistance.…”
Section: Discussionmentioning
confidence: 99%